Ovarian cancer Trials in Pittsburgh, United States
Conditions / Ovarian cancer / Pittsburgh, United States
Clinical trials for Ovarian cancer investigate a range of treatment strategies and patient populations.
75 total trials for this combination
Showing top 10 of 75 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00109993 | Campath-1H + FK506 and Methylprednisolone for GVHD | COMPLETED | PHASE2 |
| NCT02960594 | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse | COMPLETED | PHASE1 |
| NCT04585750 | The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) | RECRUITING | PHASE1/PHASE2 |
| NCT02178722 | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers | COMPLETED | PHASE1/PHASE2 |
| NCT05259696 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) | COMPLETED | PHASE1/PHASE2 |
| NCT04421963 | Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib | ACTIVE_NOT_RECRUITING | — |
| NCT02012699 | Integrated Cancer Repository for Cancer Research | RECRUITING | — |
| NCT04672460 | A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT03170960 | Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT05123482 | A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies | RECRUITING | PHASE1/PHASE2 |